How the New European Imaging Consensus Alters Breast Care

The medical oncology community recently welcomed a significant diagnostic milestone. Specifically, a joint European panel of 13 leading experts established a unified approach to pre-operative breast imaging [1]. Consequently, this consensus addresses the wide variation in breast cancer staging practices. Furthermore, EUSOBI launched this initiative alongside other prominent scientific organizations [1].

Current Challenges in Pre-operative Breast Imaging

Historically, physicians across Europe utilized highly varied diagnostic pathways. Therefore, patients often received inconsistent workups. To resolve these disparities, the expert panel evaluated currently available evidence. Ultimately, the panel voted on several statements regarding breast MRI, mammography, and ultrasound [1]. Specifically, they achieved a consensus on 67.4% of the statements, while reaching a majority on 28.3% [1]. In contrast, they reached no decision on only 4.3% of the proposed clinical questions [1].

The New Clinical Staging Toolbox

As a result, this new consensus provides clinicians with a practical working toolbox [1]. For example, the toolbox defines the specific scenarios where breast MRI is most beneficial. Indeed, recent clinical trials suggest that routine breast MRI might not benefit every early-stage patient [2]. Moreover, selective use of advanced imaging can prevent unnecessary surgical delays and reduce overall costs [2]. Additionally, Indian oncologists can adapt these clinical pathways to optimize resource utilization in local healthcare settings. Consequently, by streamlining the staging process, multidisciplinary teams can deliver highly personalized and efficient care.

Integrating Guidelines into Practice

For instance, clinicians must balance imaging sensitivity with the risk of false-positive results [2, 3]. Thus, the new guidelines advocate for selective rather than routine preoperative breast MRI. In particular, this selective approach benefits patients with invasive lobular carcinoma or extremely dense breasts [1]. On the other hand, routine MRI for low-risk, early-stage cancers might lead to overdiagnosis [2]. Therefore, Indian clinicians should evaluate each patient individually using the consensus toolbox [1].

Frequently Asked Questions

Q1: Why did the European scientific societies develop this new consensus?

They developed it because breast cancer staging practices varied highly across Europe. Consequently, this consensus establishes a common understanding of the evidence required for optimal pre-operative diagnostic tests.

Q2: What was the level of agreement achieved by the expert panel?

The panel reached a consensus on 67.4% of the statements and questions. Additionally, they reached a majority agreement on 28.3% and made no decision on 4.3% of them.

Q3: How does this consensus help breast cancer specialists in their clinical practice?

It provides a practical staging toolbox based on current scientific evidence and expert opinions. Consequently, clinicians can design a more standardized and optimal pathway for breast cancer staging.

References

1. Camps-Herrero J et al. European consensus on pre-operative imaging in breast cancer developed jointly by EUSOBI, ESSO, ESP and ESTRO. Eur Radiol. 2026 Jun 16. doi: 10.1007/s00330-026-12558-9. PMID: 42301480.
2. Bedrosian I et al. SABCS 2025: Diagnostic breast MRI may be unnecessary for some patients with early-stage breast cancer. San Antonio Breast Cancer Symposium. 2025 Dec 11.
3. Cohen E et al. Auditing preoperative breast MRI is feasible under upcoming BI-RADS recommendations. Radiology. 2025 Oct 14.